Spain
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
21.29%
|
Dec. 31, 2023 | USD 68.35 | 0.94% |
|
Spain |
|
2 |
11.84%
|
Dec. 31, 2023 | USD 3.71 | 0.53% |
|
Spain |
|
3 |
6.33%
|
Dec. 31, 2023 | USD 9.99 | 0.04% |
|
Spain |
|
4 |
2.85%
|
Dec. 31, 2023 | USD 2.67 | -0.53% |
|
Spain |
|
5 |
0.33%
|
Dec. 31, 2023 | USD 95.61 | 0.58% |
|
Spain |
|
6 |
0.28%
|
Dec. 31, 2023 | USD 8.61 | 2.23% |
|
Spain |
|
7 |
-1.62%
|
Dec. 31, 2023 | USD 9.63 | -2.28% |
|
Spain |
|
8 |
-7.25%
|
Dec. 31, 2023 | USD 3.65 | -1.71% |
|
Spain |
|
9 |
-16.15%
|
Dec. 31, 2023 | USD 1.81 | -0.12% |
|
Spain |
The Healthcare company in Spain with the highest Return on Assets (ROA) is Laboratorios Farmaceuticos Rovi, S.A. (MCE: ROVI.MC) at 21.29%.
The Healthcare company in Spain with the lowest Return on Assets (ROA) is Pangaea Oncology, S.A. (MCE: PANG.MC) at -16.15%.
The top 10 Healthcare companies in Spain by Return on Assets (ROA) are Laboratorios Farmaceuticos Rovi, S.A., Faes Farma, S.A., Prim, S.A., Laboratorio Reig Jofre, S.A., Pharma Mar, S.A., Grifols, S.A., Almirall, S.A., Atrys Health, S.A. and Pangaea Oncology, S.A..
The bottom 10 Healthcare companies in Spain by Return on Assets (ROA) are Pangaea Oncology, S.A., Atrys Health, S.A., Almirall, S.A., Grifols, S.A., Pharma Mar, S.A., Laboratorio Reig Jofre, S.A., Prim, S.A., Faes Farma, S.A. and Laboratorios Farmaceuticos Rovi, S.A..